FDA shifts the bar for priority medical AI
Previously, an AI could earn breakthrough device status just by matching a doctor's performance, only faster. STAT News reports the FDA is now favoring AI that does something no doctor can do at all, like spotting multiple cancers on a single scan or predicting mortality risk from cancer or heart failure. That changes which tools show up in clinics first.
practitioners › STAT News analysis, April 2, 2026, on FDA breakthrough device designations, featuring examples of multi-cancer detection from single scans and cancer/heart-failure mortality prediction.
STAT News →